Patient identification Platform (Patient I.P.) Email Format
PharmaceuticalsNew York, United States11-50 Employees
The Patient Identification Platform, known as Patient IP, provides automated matching of digital patient records to trial inclusion criteria to rapidly identify potential participants for clinical studies. The results are shown with visual displays and analytics to help researchers assess enrollment feasibility and refine trial design. The platform is fully HIPAA-compliant and can support research design, protocol modeling, and feasibility testing. Based in Rochester, New York, the company operates in the pharmaceutical manufacturing sector with a relatively small to mid-sized team. Its target customers include providers and research teams seeking deeper patient engagement and a more active role in bringing new therapies to market, aiming to address enrollment, retention, and timeline challenges in trials with individualized criteria.